Stock Earnings
Understanding the Risks of Investing in Clearside Biomedical Inc (CLSD)
Clearside Biomedical Inc’s recent filing unveils that its Director Thorp Clay acquired Company’s shares for reported $13800.0 on Feb 24
Menu
Clearside Biomedical Inc’s recent filing unveils that its Director Thorp Clay acquired Company’s shares for reported $13800.0 on Feb 24
Clearside Biomedical Inc’s recent filing unveils that its Director Thorp Clay acquired Company’s shares for reported $13800.0 on Feb 24
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Clearside Biomedical Inc revealed its Director Thorp Clay acquired Company’s shares for reported $13800.0 on Feb 24
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Clearside Biomedical